Literature DB >> 6407296

Intracoronary thrombus in nontransmural myocardial infarction and in unstable angina pectoris.

J B Mandelkorn, N M Wolf, S Singh, J A Shechter, R I Kersh, D M Rodgers, M B Workman, L G Bentivoglio, S M LaPorte, S G Meister.   

Abstract

Although intracoronary thrombus formation plays a major role in acute transmural myocardial infarction (MI), its occurrence in unstable angina (UA) and nontransmural MI has not clearly been established. To determine whether intracoronary thrombus does occur in these syndromes, coronary arteriography was performed before, during, and after intracoronary nitroglycerin and streptokinase infusion in 17 patients. None of the 8 patients with nontransmural MI and 1 of the 9 patients with UA responded to intracoronary nitroglycerin. Seven of 8 patients with nontransmural MI and 4 of 9 patients with UA responded to streptokinase infusion with opening of an occluded vessel, an increase in stenotic diameter, dissolution of an intracoronary filling defect, or a combination of these. Serial opening and closing of ischemia-related vessels occurred spontaneously and in response to streptokinase in some patients in whom thrombolysis was demonstrated. Evidence of thrombolysis was not seen in any patient studied longer than 1 week from the onset of the rest pain syndrome. The finding of thrombolysis in several patients with nontransmural MI and UA suggests that intracoronary thrombus formation plays a pathogenetic role in some patients with these ischemic syndromes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407296     DOI: 10.1016/0002-9149(83)90059-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

Review 1.  Vessel wall-related risk factors in acute vascular events.

Authors:  L Badimon; J J Badimon; M Cohen; J H Chesebro; V Fuster
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 2.  The Jeremiah Metzger lecture. Participation of eicosanoids in the syndromes of myocardial ischemia.

Authors:  J A Oates
Journal:  Trans Am Clin Climatol Assoc       Date:  1990

Review 3.  Bimodal presentation of the clinical syndromes of coronary atherosclerosis: a review.

Authors:  P J Commerford
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

4.  A rational scientific basis for subclassification of antiarrhythmic drugs.

Authors:  D C Harrison
Journal:  Trans Am Clin Climatol Assoc       Date:  1986

5.  Left ventricular thrombectomy in the early postinfarction period.

Authors:  A Smolinsky; Z Ziskind; R Mohr; D A Goor; M Motro
Journal:  Thorax       Date:  1990-07       Impact factor: 9.139

6.  Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.

Authors:  Manabu Horii; Shiro Uemura; Masahito Uemura; Masanori Matsumoto; Hiromichi Ishizashi; Keiichi Imagawa; Hajime Iwama; Yukiji Takeda; Hiroyuki Kawata; Tamio Nakajima; Yoshihiro Fujimura; Yoshihiko Saito
Journal:  Heart Vessels       Date:  2008-09-20       Impact factor: 2.037

7.  Heart rate variability and its relation to ventricular arrhythmias in congestive heart failure.

Authors:  L Fei; P J Keeling; J S Gill; Y Bashir; D J Statters; J Poloniecki; W J McKenna; A J Camm
Journal:  Br Heart J       Date:  1994-04

Review 8.  Use of nitrates in the treatment of unstable and variant angina.

Authors:  R Nordlander
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 9.  Aspirin in cardiovascular disease.

Authors:  I A Reilly; G A FitzGerald
Journal:  Drugs       Date:  1988-02       Impact factor: 9.546

Review 10.  Indications for coronary angioplasty in acute myocardial ischemic syndromes.

Authors:  P J de Feyter; P W Serruys; P G Hugenholtz
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.